Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria

A highly sensitive adenylate cyclase assay

1974 • 4,213 citations

Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells.

1981 • 1,655 citations

Tetrodotoxin, saxitoxin and their significance in the study of excitation phenomena.

1966 • 809 citations

Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein.

1981 • 735 citations

Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

1981 • 716 citations

THE INFLUENCE OF THE INTERVAL BETWEEN BEATS ON MYOCARDIAL CONTRACTILITY.

1963 • 569 citations

Cyclic AMP and contractile activity in heart.

1977 • 291 citations

Glucagon

1968 • 245 citations

Stimulation of forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase.

1982 • 240 citations

β-Adrenoceptor Antagonists: New Drugs and New Indications

1981 • 231 citations

Advances in cyclic nucleotide research Vol. 14

1982 • 225 citations

Cyclic AMP and contractile activity in heart.

1977 • 195 citations

Regulation of adenylate cyclase of human platelet membranes by forskolin.

1982 • 178 citations

The positive inotropic-acting forskolin, a potent adenylate cyclase activator.

1981 • 169 citations

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties

1979 • 159 citations

Peptidergic innervation of the mammalian sinus nodes: Vasoactive intestinal polypeptide, neurotensin, substance P

1981 • 121 citations

High efficiency coupling between beta-adrenergic receptors and cardiac contractility: direct evidence for "spare" beta-adrenergic receptors.

1979 • 75 citations

Forskolin requires more than the catalytic unit to activate adenylate cyclase

1982 • 70 citations

Cardiovascular effects of secretin

1970 • 64 citations

Evidence that forskolin activates turkey erythrocyte adenylate cyclase through a noncatalytic site

1983 • 60 citations

Secretin and VIP-stimulated adenylate cyclase from rat heart

1980 • 56 citations

Characterization of glucagon-induced changes in rate, contractility and cyclic AMP levels in isolated cardiac preparations of the rat and guinea pig.

1981 • 42 citations

Vasoactive Intestinal Peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes

1982 • 42 citations

High efficiency coupling between beta-adrenergic receptors and cardiac contractility: direct evidence for "spare" beta-adrenergic receptors.

1979 • 38 citations

Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal species

1983 • 36 citations

Inhibition of Forskolin‐stimulated cardiac adenylate cyclase activity by short‐chain alcohols

1983 • 18 citations

EFFECT OF SECRETIN ON PACEMAKER ACTIVITY AND CONTRACTILITY IN THE ISOLATED BLOOD-PERFUSED ATRIUM OF THE DOG

1976 • 15 citations

The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (fa/?) Zucker rats

1983 • 13 citations

A possible mechanism of inotropic action of prolactin on rat heart

1982 • 12 citations